D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Penske Automotive Group
PAG
$11.9B
| $4.08M | ﹤0.01% |
25,170
-46,494
| -65% | -$7.53M |
|
1252
Aclaris Therapeutics
ACRS
$211M
| $4.07M | ﹤0.01% |
3,282,982
+1,343,972
| +69% | +$1.67M |
|
1253
Belden
BDC
$5.21B
| $4.07M | ﹤0.01% |
43,909
-45,213
| -51% | -$4.19M |
|
1254
Insulet
PODD
$24.1B
| $4.06M | ﹤0.01% |
23,671
+20,252
| +592% | +$3.47M |
|
1255
C4 Therapeutics
CCCC
$189M
| $4.06M | ﹤0.01% |
496,543
+252,905
| +104% | +$2.07M |
|
1256
HEICO Class A
HEI.A
$34.9B
| $4.05M | ﹤0.01% |
26,321
+21,843
| +488% | +$3.36M |
|
1257
BrightView Holdings
BV
$1.32B
| $4.04M | ﹤0.01% |
339,745
-70,554
| -17% | -$840K |
|
1258
Shoals Technologies Group
SHLS
$1.15B
| $4.03M | ﹤0.01% |
360,743
-862,379
| -71% | -$9.64M |
|
1259
Compass Minerals
CMP
$753M
| $4.03M | ﹤0.01% |
255,967
+211,708
| +478% | +$3.33M |
|
1260
Glaukos
GKOS
$4.75B
| $4.03M | ﹤0.01% |
42,716
-231,516
| -84% | -$21.8M |
|
1261
QuinStreet
QNST
$930M
| $4.01M | ﹤0.01% |
227,215
-143,824
| -39% | -$2.54M |
|
1262
Accuray
ARAY
$177M
| $4.01M | ﹤0.01% |
1,621,808
-293,777
| -15% | -$726K |
|
1263
Daktronics
DAKT
$1.14B
| $4M | ﹤0.01% |
401,743
-18,609
| -4% | -$185K |
|
1264
Pulmonx
LUNG
$69.3M
| $4M | ﹤0.01% |
431,297
-191,291
| -31% | -$1.77M |
|
1265
OSI Systems
OSIS
$3.95B
| $3.99M | ﹤0.01% |
27,971
-7,313
| -21% | -$1.04M |
|
|
CTEV
1266
Claritev Corporation
CTEV
$1.01B
| $3.98M | ﹤0.01% |
122,694
-8,401
| -6% | -$273K |
|
|
NGD
1267
New Gold Inc
NGD
$5.16B
| $3.95M | ﹤0.01% |
2,330,886
+1,455,702
| +166% | +$2.47M |
|
1268
Sunrun
RUN
$3.71B
| $3.94M | ﹤0.01% |
298,939
-4,115,825
| -93% | -$54.2M |
|
1269
Commault Systems
CVLT
$7.82B
| $3.92M | ﹤0.01% |
38,648
-2,265
| -6% | -$230K |
|
1270
Box
BOX
$4.7B
| $3.92M | ﹤0.01% |
138,397
-112,298
| -45% | -$3.18M |
|
1271
Griffon
GFF
$3.61B
| $3.91M | ﹤0.01% |
53,272
-46,657
| -47% | -$3.42M |
|
1272
Steel Dynamics
STLD
$19.2B
| $3.9M | ﹤0.01% |
26,303
-167,219
| -86% | -$24.8M |
|
1273
Anika Therapeutics
ANIK
$125M
| $3.9M | ﹤0.01% |
153,489
-15,755
| -9% | -$400K |
|
1274
American Superconductor
AMSC
$2.54B
| $3.89M | ﹤0.01% |
288,195
-147,549
| -34% | -$1.99M |
|
1275
Olin
OLN
$3.02B
| $3.88M | ﹤0.01% |
65,937
-1,339
| -2% | -$78.7K |
|